Raymond James Financial Services Advisors’s Avidity Biosciences RNA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio RNA Stock Details RNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$5.3M	Buy
2024 Q2	$4.58M	Sell
2024 Q1	$3.05M	Buy
2023 Q4	$784K	Buy
2023 Q3	$222K	Buy
2023 Q2	$289K	Sell
2023 Q1	$563K	Buy
2022 Q4	$348K	Buy